CompletedNot Applicable

SHERLOCK 3CG vs. Fluoroscopy in Implantation of PICC-Line

Germany210 participantsStarted 2016-06

Plain-language summary

Peripherally inserted central catheters, or PICC lines, has now been successfully in use for many years, especially in the chemotherapeutic treatment of oncologic patients or in parenertal nutrition. The implantation of PICC lines is mostly performed under x-ray (fluoroscopy). The aim of the clinical study is to assess the safety and the efficacy of the SHERLOCK-Systems eliminating the confirmatory chest x-ray exposure. Additionally, the SHERLOCK-System immediately confirms the PICC tip position even at the bedside of the patient, thus, saving costs and time.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * female, male * adults ≥ 18 years * medical indication for Power-PICC-Line catheter implantation because of chemotherapy or parenertal nutrition * in- and outpatients Exclusion Criteria: * children and adolescents \< 18 years * systemic or local infection of the interventional location * known allergy to used material * general contraindication of Power-PICC-Line catheter implantation * nonexistent sinus rhythm (5)

What they're measuring

Tip Placement efficiency measured by chest radiograph

Timeframe: through study completion, an average of 2 years

Trial details

NCT IDNCT02929368

SponsorJena University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-02

View on ClinicalTrials.gov More Patients With PICC-Line trials